ArticleInternational journal of clinical oncology2026
Identifying immune-related predictive factors for post-eribulin therapy in patients with HER2-negative advanced breast cancer- a multicenter retrospective study.
Yuri Takamatsu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.